FDA Advisory Panel Evaluates Compounding Rights for High Demand Peptides

By Theresa Gaffney · STAT News · 2026-07-23

FDA Advisory Panel Evaluates Compounding Rights for High Demand Peptides

According to STAT News, a federal advisory committee is beginning two days of hearings to determine if compounding pharmacies should be permitted to manufacture seven specific peptides currently labeled as unsafe for such production. The move reflects a push by Health Secretary R

According to STAT News, a federal advisory committee is beginning two days of hearings to determine if compounding pharmacies should be permitted to manufacture seven specific peptides currently labeled as unsafe for such production. The move reflects a push by Health Secretary R